FDA
-
-
-
-
-
-
-
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
PolyPid advances D-PLEX100 partnership talks, plans NDA filing
-
-
-
-
-
-
-
PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
-
-
-
-
-
-
-
PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
PolyPid (PYPD) Provides Positive Regulatory Update for D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
-
-
-
-
-
-
-
PolyPid Ltd. (PYPD) Announces Cost Reduction Plan
-
326,549 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

